title: Sarcomatoid peritoneal malignant mesothelioma.
authors.affiliation: Gastrointestinal Division, Urasoe General Hospital, Japan. mnakamura2@jin-aikai.or.jp
authors.forename: Masamoto
authors.initials: M
authors.lastname: Nakamura
authors.forename: Kasen
authors.initials: K
authors.lastname: Kobashikawa
authors.forename: Nobufumi
authors.initials: N
authors.lastname: Uchima
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Hirata
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D064032:Calbindin 2; D002945:Cisplatin / Q000627:therapeutic use; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology*; D010534:Peritoneal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology*; D010537:Peritoneum / Q000378:metabolism / Q000473:pathology*; D064030:S100 Calcium Binding Protein G / Q000378:metabolism; D000093542:Gemcitabine
chemical_list: D064032:Calbindin 2; D064030:S100 Calcium Binding Protein G; D003841:Deoxycytidine; D002945:Cisplatin; D000093542:Gemcitabine